Actively Recruiting
Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan
Led by Pakistan Institute of Living and Learning · Updated on 2026-03-18
26376
Participants Needed
1
Research Sites
185 weeks
Total Duration
On this page
Sponsors
P
Pakistan Institute of Living and Learning
Lead Sponsor
U
University of Sheffield
Collaborating Sponsor
AI-Summary
What this Trial Is About
Breast cancer is the most common cancer among women worldwide, and many survivors experience comorbid mental health conditions such as depression and anxiety, which can significantly worsen health outcomes and increase mortality. This large-scale trial in Pakistan aims to evaluate the clinical and cost-effectiveness of a three-stage adaptive intervention to manage depression among breast cancer survivors. Using a Sequential, Multiple Assignment, Randomised Trial (SMART) design, the study will recruit 26,372 participants aged 18 and above who have completed initial breast cancer treatment (surgery and/or chemotherapy or radiotherapy). Participants will be identified through primary care units, outpatient departments, oncology clinics in public hospitals, and charitable organisations across Pakistan. Depression will be screened using the Patient Health Questionnaire PHQ-9, with diagnosis confirmed by the Structured Clinical Interview Schedule of DSM (SCID). Those randomised to the intervention arm will receive adaptive interventions: starting with low-intensity guided self-help, followed by a high-intensity cognitive behavioural therapy-based programme called "Moving On After Breast Cancer Plus" (Moving on ABC Plus), and for non-responders, an additional pharmacological component will be introduced. Participants in both adaptive intervention and enhance usual care groups will be assessed at multiple time points-baseline, 6, 18, 30, and 48 weeks post-randomisation-using validated tools to measure depression (primary outcome), and anxiety, self-esteem, intrusive thoughts, health-related quality of life, satisfaction with services, and health resource use (secondary outcomes). The study will also include qualitative interviews and focus groups discussions with patients, caregivers, healthcare providers, and policymakers to identify barriers and facilitators to implementation and ensure the intervention is both contextually appropriate and scalable.
CONDITIONS
Official Title
Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women
- Aged 18 years and above
- Diagnosed with breast cancer (any stage)
- Completed initial treatment (surgery and/or radiotherapy or chemotherapy) for breast cancer
- Score of 10 or above on the Patient Health Questionnaire (PHQ-9)
- Diagnosis of current Major Depressive Episode confirmed using the Structured Clinical Interview for DSM-5 (SCID)
You will not qualify if you...
- Unable to give informed consent due to intellectual disabilities, dementia, or severe medical or psychiatric illness requiring hospitalization
- Unable to participate in assessments or interventions due to severe symptoms from stage 4 breast cancer
- Currently receiving psychological therapy or taking antidepressant medications such as SSRIs or SNRIs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pakistan Institute of Living and Learning
Karachi, Sindh, Pakistan, 75600
Actively Recruiting
Research Team
T
Tayyeba Kiran, PhD
CONTACT
N
Nasim Chaudhry, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here